These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23739335)

  • 41. Functional characterization of p7 viroporin from hepatitis C virus produced in a cell-free expression system.
    Soranzo T; Cortès S; Gilde F; Kreir M; Picart C; Lenormand JL
    Protein Expr Purif; 2016 Feb; 118():83-91. PubMed ID: 26477501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The 3-dimensional structure of a hepatitis C virus p7 ion channel by electron microscopy.
    Luik P; Chew C; Aittoniemi J; Chang J; Wentworth P; Dwek RA; Biggin PC; Vénien-Bryan C; Zitzmann N
    Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12712-6. PubMed ID: 19590017
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative NMR studies demonstrate profound differences between two viroporins: p7 of HCV and Vpu of HIV-1.
    Cook GA; Zhang H; Park SH; Wang Y; Opella SJ
    Biochim Biophys Acta; 2011 Feb; 1808(2):554-60. PubMed ID: 20727848
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential Binding of Rimantadine Enantiomers to Influenza A M2 Proton Channel.
    Wright AK; Batsomboon P; Dai J; Hung I; Zhou HX; Dudley GB; Cross TA
    J Am Chem Soc; 2016 Feb; 138(5):1506-9. PubMed ID: 26804976
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pore-forming activity of pestivirus p7 in a minimal model system supports genus-specific viroporin function.
    Largo E; Gladue DP; Huarte N; Borca MV; Nieva JL
    Antiviral Res; 2014 Jan; 101():30-6. PubMed ID: 24189547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. "Too little, too late?" Will inhibitors of the hepatitis C virus p7 ion channel ever be used in the clinic?
    Griffin S
    Future Med Chem; 2014; 6(17):1893-907. PubMed ID: 25495983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis C Virus p7 membrane protein quasispecies variability in chronically infected patients treated with interferon and ribavirin, with or without amantadine.
    Castelain S; Bonte D; Penin F; François C; Capron D; Dedeurwaerder S; Zawadzki P; Morel V; Wychowski C; Duverlie G
    J Med Virol; 2007 Feb; 79(2):144-54. PubMed ID: 17177298
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two different conformations in hepatitis C virus p7 protein account for proton transport and dye release.
    Gan SW; Surya W; Vararattanavech A; Torres J
    PLoS One; 2014; 9(1):e78494. PubMed ID: 24409277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel.
    Jing X; Ma C; Ohigashi Y; Oliveira FA; Jardetzky TS; Pinto LH; Lamb RA
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10967-72. PubMed ID: 18669647
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The p7 protein of hepatitis C virus forms structurally plastic, minimalist ion channels.
    Chandler DE; Penin F; Schulten K; Chipot C
    PLoS Comput Biol; 2012; 8(9):e1002702. PubMed ID: 23028296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Flu channel drug resistance: a tale of two sites.
    Pielak RM; Chou JJ
    Protein Cell; 2010 Mar; 1(3):246-58. PubMed ID: 21203971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [New adamantane derivatives and ways of overcoming the resistance of influenza A viruses to rimantadine and amantadine].
    Shibnev VA; Garayev TM; Finogenova MP; Shevchenko ES; Burtseva EI
    Vopr Virusol; 2011; 56(2):36-9. PubMed ID: 21545040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction of influenza virus proteins with planar bilayer lipid membranes. II. Effects of rimantadine and amantadine.
    Tverdislov VA; El Karadaghi S; Bucher DJ; Zakomirdin JA; Kharitonenkov IG
    Biochim Biophys Acta; 1984 Dec; 778(2):276-80. PubMed ID: 6498193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genotype-specific differences in structural features of hepatitis C virus (HCV) p7 membrane protein.
    Kalita MM; Griffin S; Chou JJ; Fischer WB
    Biochim Biophys Acta; 2015 Jun; 1848(6):1383-92. PubMed ID: 25772504
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine.
    Griffin SD; Beales LP; Clarke DS; Worsfold O; Evans SD; Jaeger J; Harris MP; Rowlands DJ
    FEBS Lett; 2003 Jan; 535(1-3):34-8. PubMed ID: 12560074
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural and functional analysis of the HCV p7 protein.
    Saint N; Montserret R; Chipot C; Penin F
    Methods Mol Biol; 2009; 510():125-43. PubMed ID: 19009258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
    Moorthy NS; Poongavanam V; Pratheepa V
    Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The N-terminal Helical Region of the Hepatitis C Virus p7 Ion Channel Protein Is Critical for Infectious Virus Production.
    Scull MA; Schneider WM; Flatley BR; Hayden R; Fung C; Jones CT; van de Belt M; Penin F; Rice CM
    PLoS Pathog; 2015 Nov; 11(11):e1005297. PubMed ID: 26588073
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of a novel class of cyclic penta-peptides against hepatitis C virus as p7 channel blockers.
    Wei S; Liu C; Du L; Wu B; Zhong J; Tong Y; Wang S; OuYang B
    Comput Struct Biotechnol J; 2022; 20():5902-5910. PubMed ID: 36382186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The p7 protein of the hepatitis C virus induces cell death differently from the influenza A virus viroporin M2.
    Aweya JJ; Mak TM; Lim SG; Tan YJ
    Virus Res; 2013 Mar; 172(1-2):24-34. PubMed ID: 23246447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.